MPZ-T124M mouse model replicates human axonopathy and suggest alteration in axo-glia communication
Ghjuvan’Ghjacumu ShacklefordiD, Leandro N. MarzialiiD, Yo SasakiiD, Nadav I. WeinstockiD, Alexander Martin RossoriD, Nicholas J. SilvestriiD, Emma R. WilsoniD, Edward L. HurleyiD, Grahame J. KiddiD, Senthilvelan ManohariD, Dalian DingiD, Richard SalviiD, M. Laura FeltriiD, Maurizio D’AntonioiD, Lawrence G. WrabetziD
Abstract
Myelin is essential for rapid nerve impulse propagation and axon protection. Accordingly, defects in myelination or myelin maintenance lead to secondary axonal damage and subsequent degeneration. Studies utilizing genetic (CNPase-, MAG-, and PLP-null mice) and naturally occurring neuropathy models suggest that myelinating glia also support axons independently from myelin. Myelin protein zero (MPZ or P0), which is expressed only by Schwann cells, is critical for myelin formation and maintenance in the peripheral nervous system. Many mutations in MPZ are associated with demyelinating neuropathies (Charcot-Marie-Tooth disease type 1B [CMT1B]). Surprisingly, the substitution of threonine by methionine at position 124 of P0 (P0T124M) causes axonal neuropathy (CMT2J) with little to no myelin damage. This disease provides an excellent paradigm to understand how myelinating glia support axons independently from myelin. To study this, we generated targeted knock-in P0T124M mutant mice, a genetically authentic model of T124M-CMT2J neuropathy. Similar to patients, these mice develop axonopathy between 2 and 12 months of age, characterized by impaired motor performance, normal nerve conduction velocities but reduced compound motor action potential amplitudes, and axonal damage with only minor compact myelin modifications. Mechanistically, we detected metabolic changes that could lead to axonal degeneration, and prominent alterations in non-compact myelin domains such as paranodes, Schmidt-Lanterman incisures, and gap junctions, implicated in Schwann cell-axon communication and axonal metabolic support. Finally, we document perturbed mitochondrial size and distribution along P0T124M axons suggesting altered axonal transport. Our data suggest that Schwann cells in P0T124M mutant mice cannot provide axons with sufficient trophic support, leading to reduced ATP biosynthesis and axonopathy. In conclusion, the P0T124M mouse model faithfully reproduces the human neuropathy and represents a unique tool for identifying the molecular basis for glial support of axons.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuromotor impairment, hearing loss and blindness in a preclinical mouse model of Charcot Marie-Tooth disorder
Sergio González-González, Chantal Cazevieille·bioRxiv·Jun 2, 2020
- CMT disease 2A and demyelination decouple ATP and ROS production by axonal mitochondria
Gerben van Hameren, Graham R. Campbell, … Nicolas Tricaud·bioRxiv·Dec 4, 2018
- A nonsense mutation in Myelin Protein Zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function
Pietro Fratta, Francesca Ornaghi, … Lawrence G. Wrabetz·Human Molecular GeneticsPeer-reviewed·Sep 18, 2018
- Genetically perturbed myelin as a risk factor for neuroinflammation-driven axon degeneration
Janos Groh, Tassnim Abdelwahab, … Rudolf Martini·Nature CommunicationsPeer-reviewed·Oct 30, 2023
- Aberrant Molecular Myelin Architecture in Charcot-Marie-Tooth Disease Type 1A and Hereditary Neuropathy with Liability to Pressure Palsies
Kathryn R. Moss, Marvis Ayoola Arowolo, … Ahmet Höke·GliaPeer-reviewed·Dec 16, 2025
- Genetic ablation of Sarm1 attenuates axonal degeneration in a mouse model of CMT2J
Anke Claessens, Roberta De Blasis, … Maurizio D’Antonio·bioRxiv·Oct 29, 2026